Role of intestinal flora in the development of allergy

被引:86
作者
Kalliomaki, Marko
Isolauri, Erika
机构
[1] Univ Turku, Dept Pediat, Turku, Finland
[2] Turku Univ Hosp, Turku, Finland
关键词
allergic disease; atopy; gut microbiota; probiotics; toll-like receptors;
D O I
10.1097/01.all.0000053262.39029.a1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review The frequency of allergic diseases is increasing worldwide. Experimental and clinical studies have linked a reduced number of early infections to this trend. The gastrointestinal system, which comprises the largest lymphoid tissue and microbial reservoir of the body, has received more attention during the last few years as a potential determiner in the development of atopic disease. Recent findings Alterations in intestinal microbiota have been detected both in infants suffering from allergic disease and in those later developing the disorder. Delay in the compositional development of Bifidobacterium and Lactobacillus in gut microflora was a general finding in allergic children. In a subsequent study, perinatal administration of lactobacilli halved the later development of atopic eczema during the first 2 years of life. Specific strains of the healthy gut microbiota have been shown to induce the production of IL-10 and transforming growth factor-beta, which possess an important regulative role in the development of allergic type immune response. Probiotics also strengthen gut defence barrier mechanisms and reduce antigen load in the gut. Pattern recognition receptors in intestinal epithelial and antigen-presenting cells have been demonstrated to mediate a continuing dialogue between host and gut microbiota. Summary Despite several promising findings, the exact role of gut normal microbiota in the development of allergy remains to be elucidated. For successful interventions, more data concerning a communication between host and specific microbial species are needed.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 70 条
  • [21] Intestinal Bifidobacterium species induce varying cytokine production
    He, F
    Morita, H
    Hashimoto, H
    Hosoda, M
    Kurisaki, JI
    Ouwehand, AC
    Isolauri, E
    Benno, Y
    Salminen, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) : 1035 - 1036
  • [22] No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy:: a placebo-controlled double-blind study
    Helin, T
    Haahtela, S
    Haahtela, T
    [J]. ALLERGY, 2002, 57 (03) : 243 - 246
  • [23] The epidemic of allergy and asthma
    Holgate, ST
    [J]. NATURE, 1999, 402 (6760) : B2 - B4
  • [24] Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x
  • [25] Isolauri E, 2002, GUT S3, V50
  • [26] Cutting edge:: Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB
    Jiang, QQ
    Akashi, S
    Miyake, K
    Petty, HR
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (07) : 3541 - 3544
  • [27] Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both
    Jones, CA
    Holloway, JA
    Popplewell, EJ
    Diaper, ND
    Holloway, JW
    Vance, GHS
    Warner, JA
    Warner, JO
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (05) : 858 - 866
  • [28] Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
    Kalliomäki, M
    Kirjavainen, P
    Eerola, E
    Kero, P
    Salminen, S
    Isolauri, E
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) : 129 - 134
  • [29] Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial
    Kalliomäki, M
    Salminen, S
    Arvilommi, H
    Kero, P
    Koskinen, P
    Isolauri, E
    [J]. LANCET, 2001, 357 (9262) : 1076 - 1079
  • [30] Could TH1 and TH2 diseases coexist?: Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis:: A register study
    Kero, J
    Gissler, M
    Hemminki, E
    Isolauri, E
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (05) : 781 - 783